Página 10 - Melhores Médicos em Israel — Obtenha uma consulta online

O médico é especializado em deformidades da coluna vertebral em adultos e crianças, cirurgia robótica da coluna, hérnias intervertebrais, tumores da coluna e lesões da coluna vertebral.<\/p>

Graduou-se na Universidade Hebraica e completou treinamento avançado em cardiologia, ressuscitação de trauma e traumatologia ortopédica. Completou residência em ortopedia no Hospital Universitário Hadassah e treinamento adicional em vertebrologia pediátrica.<\/p>

Trabalhou como cirurgião de coluna no Hospital do Bronx e atualmente pratica em Israel, utilizando equipamentos robóticos para cirurgias complexas da coluna. Envolve-se em pesquisa científica, ensino e publicou numerosos artigos em vertebrologia.<\/p>

O médico é um hematologista distinto e especialista em transplante de medula óssea com mais de 15 anos de experiência no Hospital Universitário Hebraico Hadassah. Ele desempenhou um papel fundamental como Diretor Médico do Registro Público de Medula Óssea Hadassah e do Banco Nacional de Sangue de Israel. O médico possui um diploma de medicina da Universidade de Milão e completou pesquisas pós-doutorais na Universidade Médica do Colorado. Ele possui uma cátedra associada da Universidade Hebraica de Jerusalém e publicou numerosos artigos em revistas médicas.

O médico foi premiado com o Prêmio Menachem Begin em 2008 e fundou um laboratório de pesquisa. Atualmente, ele atua como Chefe do Departamento de Hematologia, Imunoterapia do Câncer, Terapia Celular e Transplante de Medula Óssea no Hospital Universitário Hebraico Hadassah.

O médico é um especialista altamente qualificado em Oncologia Pediátrica e Hemato-Oncologia no Centro Médico Hadassah, reconhecido na lista da Forbes dos melhores médicos em Israel de 2019-2020. Com mais de vinte anos de especialização em pediatria, hemato-oncologia pediátrica e transplante de medula óssea haploidêntico, o médico é uma figura proeminente no campo.<\/p>

O médico é graduado pela Universidade de Tel Aviv e está ativamente envolvido em associações profissionais, incluindo a Sociedade Israelense de Hematologia e Oncologia Pediátrica, a Associação Israelense de Câncer, a Associação Internacional de Oncologia e a Sociedade Internacional de Oncologia Pediátrica. Os principais campos de interesse incluem retinoblastoma, medicina de precisão e oncologia pediátrica.<\/p>

O médico formou-se na Faculdade de Medicina da Universidade Hebraica em 1987 e especializa-se em Cirurgia e Cirurgia Colorretal. Afiliado ao Centro Médico Hadassah, o médico é Instrutor em Cirurgia desde 1995, Professor desde 1999 e Professor Sênior desde 2005. O médico dirige o Programa de Estudantes de Medicina no Departamento de Cirurgia desde 1997 e é Diretor do Programa de Residência no Departamento de Cirurgia desde 2000. Certificado em Cirurgia Geral em Israel desde 1998, o médico também é membro de várias associações cirúrgicas.<\/p>

O médico é especializado em alongamento de membros e operações reconstrutivas usando o método Ilizarov, focando na correção de deformidades dos membros e no tratamento de condições pós-traumáticas. A expertise inclui tratamentos de fraturas cirúrgicos e não cirúrgicos, tratamentos de artrite preservando as articulações e cuidados ortopédicos para paralisia cerebral. O médico formou-se na Universidade Hebraica de Jerusalém e completou uma especialização em ortopedia no Centro Médico Hadassah, com formação adicional no Hospital for Special Surgery em Nova York. Envolvido ativamente na educação médica e pesquisa, o médico é membro de sociedades ortopédicas proeminentes.<\/p>

O médico é reconhecido como um dos principais neurocirurgiões globalmente e o principal cirurgião de coluna em Israel, de acordo com a Associação Médica de Israel. Formado pela Universidade Nacional de Pesquisa Médica da Rússia, o médico aprimorou ainda mais sua expertise nos EUA, Suíça, França, Itália e Áustria.<\/p>

Especializando-se em tratamentos cirúrgicos e não cirúrgicos, o médico foca em hérnias de disco, escoliose, estreitamento do espaço discal e reabilitação neurocirúrgica, utilizando técnicas minimamente invasivas para distúrbios da coluna em adultos e crianças. Realizando aproximadamente 60 cirurgias mensais, o médico é membro da Associação Ortopédica de Israel, da Sociedade de Coluna de Israel e da Sociedade de Coluna da Europa.<\/p>

O médico é oncologista clínico e radioterapeuta com 33 anos de experiência, especializado em oncologia e radioterapia. Formou-se no Hospital Universitário Hadassah em Jerusalém, Israel, e possui qualificações em oncologia e radioterapia.<\/p>

Atualmente, atua como chefe do Centro de Câncer Gastrointestinal e também é médico sênior no Departamento de Oncologia do Hospital Universitário Hadassah. Completou os exames de certificação em oncologia e radioterapia e é membro de várias sociedades profissionais, incluindo a Sociedade Israelense de Oncologia Clínica e a Associação Israelense de Câncer.<\/p>

Professor Pnina Langevich is a rheumatologist and immunologist with over 40 years of experience. She leads the National Center for Rheumatology and Autoimmune Diseases at Sheba Medical Center. Forbes Israel has repeatedly named her among the country’s top doctors.

She is an expert in rheumatoid arthritis, osteoarthritis, joint diseases, systemic lupus erythematosus, scleroderma, and complex autoimmune disorders. She treats severe, treatment‑resistant cases using advanced diagnostics and personalized therapy.

She trained in rheumatology and internal medicine at Sheba. She combines patient care with research on new therapies. She served for 12 years as Vice President of the World Association of Rheumatologists. She is Editor‑in‑Chief of Lupus and a member of the Israeli Medical Association and the International Association of Rheumatologists.

Dr. Anton Wohl leads the Brain Tumors Unit at Sheba Medical Center (since 2026). He is a neurosurgeon specializing in neuro-oncology, brain tumor surgery, and stereotactic radiosurgery.

He performs complex tumor operations with intraoperative MRI and functional mapping. He also uses fluorescence guidance, neuronavigation, and awake craniotomy to help remove tumors safely and preserve function.

Accreditations: Israeli Board Certification in Neurosurgery; Israeli medical license; advanced international fellowships and training, including the Mayo Clinic (USA).

Research: author and co-author of peer-reviewed publications on glioblastoma, malignant brain tumors, radiosurgery, and experimental therapies.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Prof. Gil Raviv, MD, PhD, is Director of the Andrology Unit at Sheba Medical Center. He was listed among the Best Doctors in Israel by Forbes in 2024. He is a leading expert in male fertility, sexual medicine, and reconstructive urology.

His primary focus is male infertility and fertility preservation. He performs advanced semen analysis according to WHO standards. He carries out testicular sperm retrieval (TESE, TESA, MESA) and semen cryopreservation. He also provides comprehensive fertility diagnostics with histological analysis.

He is a Professor at Tel Aviv University. He trained in Siena, Rome, and Tel Aviv. He completed a fellowship in infertility and impotence at Erasme Hospital. He received advanced training in reconstructive urethral surgery in Ghent. He is a member of the European Association of Urology, the International Society for Sexual Medicine, and the Israeli Urological Association.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Roy Mashiach, MD, is the Director of Gynecology at Sheba Medical Center. He is a leading expert in minimally invasive gynecologic surgery with over 30 years of experience. He focuses on laparoscopic and hysteroscopic hysterectomy. He also performs myoma removal, treats endometriosis, and offers fertility‑preserving procedures.

Recognition and roles: Named to Forbes Israel’s Best Doctors. Recipient of the Daniel F. Kott Award (AAGL). Chairman of the Israeli Society of Gynecological Endoscopy. Director of the Gynecologic Simulation Unit (M.S.R.). Clinical Associate Professor at Tel Aviv University. Training: MD from Tel Aviv University. Specialization at Lis Maternity & Women’s Hospital. Fellowship in Advanced Endoscopy at Université d’Auvergne.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).